A new Fast-Track HIV care model aims to Re-Engage those lost to care

NCT ID NCT06374758

Ongoing Disease control Sponsor: University of Missouri-Columbia Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study tests a simplified, accelerated HIV care model called ACCELERATE. It combines rapid telehealth appointments, a pre-approved HIV medication, and a free 30-day starter supply to help people with HIV who have fallen out of care get back on track. The goal is to see if this approach can help them achieve viral suppression by week 24 and whether it is acceptable and practical for both patients and staff.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A simplified accelerated HIV care model combining telehealth, a pre-approved HIV medication (B/F/TAF), and a free 30-day starter supply
What this could lead to: If effective, this approach could offer a practical way to re-engage people with HIV who have fallen out of care, helping them achieve viral suppression and better long-term health.
What could go wrong: The trial is relatively small and single-arm, so results may not apply broadly. Success depends on factors like patient adherence and the feasibility of the model in different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ART are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arts syndrome HIV infectious disease Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ART HIV INFECTIONS NONCOMPLIANCE, PATIENT

Contacts and locations

Locations

AIDS Project of the Ozarks

Springfield, Missouri, 65804, United States
KC Care Health Center

Kansas City, Missouri, 64124, United States
NOVUS Health

St Louis, Missouri, 63111, United States
University of Missouri-Columbia

Columbia, Missouri, 65212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.